Over the past 12 months, BridgeBio Oncology Therapeutics insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bihua Chen | Director, TenPercentOwner | 0 | 21,357,148 | 21,357,148 | 51.9% | 06 Jul, 2026 |
| 2 | Pharma Llc Bridgebio | TenPercentOwner | 14,589,846 | 0 | 14,589,846 | 35.4% | 16 Oct, 2025 |
| 3 | Holdings Ii Llc Helix | Director, TenPercentOwner | 4,480,000 | 509,000 | 4,989,000 | 12.1% | 10 Feb, 2025 |
| 4 | Pedro Beltran | President And Ceo | 43,529 | 0 | 43,529 | 0.1% | 05 Oct, 2026 |
| 5 | Yong Ben | Chief Med Dev Officer | 43,529 | 0 | 43,529 | 0.1% | 05 Oct, 2026 |
| 6 | John P. Schmid | Other | 30,000 | 0 | 30,000 | 0.1% | 11 Aug, 2025 |
| 7 | Mark C. Mckenna | Other | 30,000 | 0 | 30,000 | 0.1% | 11 Aug, 2025 |
| 8 | Albert A Iii Holman | Other | 30,000 | 0 | 30,000 | 0.1% | 11 Aug, 2025 |
| 9 | Uneek Mehra | Chief Financial Officer | 22,806 | 0 | 22,806 | 0.1% | 05 May, 2026 |
| 10 | Idan Elmelech | Coo Principal Financial Ofcr | 14,152 | 0 | 14,152 | 0.0% | 05 Oct, 2026 |
| 11 | Marc Cobo | Principal Accounting Officer | 13,812 | 0 | 13,812 | 0.0% | 23 Oct, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 21 Oct, 2026 | Marc Cobo | Principal Accounting Officer | Disposed F | 203 | $2.68 | $544 | 13,812 | Direct |
| 01 Oct, 2026 | Yong Ben | Chief Med Dev Officer | Disposed F | 1,047 | $3.94 | $4.13K | 43,529 | Direct |
| 01 Oct, 2026 | Idan Elmelech | Coo Principal Financial Ofcr | Disposed F | 343 | $3.94 | $1.35K | 14,152 | Direct |
| 01 Oct, 2026 | Marc Cobo | Principal Accounting Officer | Disposed F | 126 | $3.94 | $496 | 14,015 | Direct |
| 01 Oct, 2026 | Pedro Beltran | President And Ceo | Disposed F | 1,047 | $3.94 | $4.13K | 43,529 | Direct |
| 10 Sep, 2026 | Marc Cobo | Principal Accounting Officer | Acquired A | 9,038 | $0.00 | $0 | 14,344 | Direct |
| 10 Sep, 2026 | Marc Cobo | Principal Accounting Officer | Disposed F | 203 | $5.52 | $1.12K | 14,141 | Direct |
| 10 Sep, 2026 | Marc Cobo | Principal Accounting Officer | Acquired A | 43,700 | $0.00 | $0 | 43,700 | Direct |
| 01 Jul, 2026 | Yong Ben | Chief Med Dev Officer | Disposed F | 1,047 | $7.80 | $8.17K | 44,576 | Direct |
| 01 Jul, 2026 | Pedro Beltran | President And Ceo | Disposed F | 1,047 | $7.80 | $8.17K | 44,576 | Direct |
| 01 Jul, 2026 | Bihua Chen | Director, TenPercentOwner | Disposed J | 4,528,186 | $0.00 | $0 | 0 | Indirect |
| 01 Jul, 2026 | Marc Cobo | Principal Accounting Officer | Disposed F | 125 | $7.80 | $975 | 5,306 | Direct |
| 01 Jul, 2026 | Idan Elmelech | Coo Principal Financial Ofcr | Disposed F | 343 | $7.80 | $2.68K | 14,495 | Direct |
| 01 Jul, 2026 | Bihua Chen | Director, TenPercentOwner | Acquired J | 2,692,459 | $0.00 | $0 | 4,879,995 | Indirect |
| 01 Jul, 2026 | Bihua Chen | Director, TenPercentOwner | Acquired J | 1,704,862 | $0.00 | $0 | 5,010,332 | Indirect |
| 01 Jul, 2026 | Bihua Chen | Director, TenPercentOwner | Acquired J | 130,865 | $0.00 | $0 | 6,083,221 | Indirect |
| 16 Jun, 2026 | Neil Kumar | Director | Acquired A | 31,675 | $0.00 | $0 | 31,675 | Direct |
| 16 Jun, 2026 | Jake Bauer | Director | Acquired A | 31,675 | $0.00 | $0 | 31,675 | Direct |
| 16 Jun, 2026 | Bihua Chen | Director, TenPercentOwner | Acquired A | 31,675 | $0.00 | $0 | 31,675 | Direct |
| 16 Jun, 2026 | Praveen P. Tipirneni | Director | Acquired A | 31,675 | $0.00 | $0 | 31,675 | Direct |